Found: 95
Select item for more details and to access through your institution.
European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well‐differentiated small intestine neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 9, p. 1, doi. 10.1111/jne.13423
- By:
- Publication type:
- Article
Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids.
- Published in:
- EJNMMI Research, 2015, v. 5, n. 1, p. 1, doi. 10.1186/s13550-015-0130-2
- By:
- Publication type:
- Article
Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids.
- Published in:
- EJNMMI Research, 2015, v. 5, n. 1, p. 1, doi. 10.1186/s13550-015-0130-2
- By:
- Publication type:
- Article
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5892, doi. 10.3390/cancers15245892
- By:
- Publication type:
- Article
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6329, doi. 10.3390/cancers13246329
- By:
- Publication type:
- Article
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3607, doi. 10.3390/cancers13143607
- By:
- Publication type:
- Article
Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3).
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1936, doi. 10.3390/cancers13081936
- By:
- Publication type:
- Article
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3448, doi. 10.3390/cancers12113448
- By:
- Publication type:
- Article
Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. e643, doi. 10.1093/oncolo/oyad325
- By:
- Publication type:
- Article
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 940, doi. 10.1093/oncolo/oyac161
- By:
- Publication type:
- Article
Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1082, doi. 10.1634/theoncologist.2018-0672
- By:
- Publication type:
- Article
Long‐Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. e662, doi. 10.1634/theoncologist.2018-0236
- By:
- Publication type:
- Article
Effect of Lanreotide Depot/Autogel on Urinary 5‐Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 463, doi. 10.1634/theoncologist.2018-0217
- By:
- Publication type:
- Article
Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 409, doi. 10.1634/theoncologist.2016-0351
- By:
- Publication type:
- Article
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Neuroendocrine tumors of midgut and hindgut origin: Tumor-node-metastasis classification determines clinical outcome.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 15, p. 3332, doi. 10.1002/cncr.25855
- By:
- Publication type:
- Article
Use and perceived utility of [<sup>18</sup>F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 1, p. 1, doi. 10.1111/jne.13359
- By:
- Publication type:
- Article
Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 6, p. 1, doi. 10.1111/jne.13310
- By:
- Publication type:
- Article
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 3, p. 1, doi. 10.1111/jne.13249
- By:
- Publication type:
- Article
The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 10, p. 1, doi. 10.1111/jne.13196
- By:
- Publication type:
- Article
High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 10, p. 1, doi. 10.1111/jne.13193
- By:
- Publication type:
- Article
Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 7, p. 1, doi. 10.1111/jne.13174
- By:
- Publication type:
- Article
ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 3, p. 1, doi. 10.1111/jne.13044
- By:
- Publication type:
- Article
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 12, p. 3741, doi. 10.1210/jc.2011-0666
- By:
- Publication type:
- Article
Gastrointestinale neuroendokrine Tumoren – Update 2024.
- Published in:
- Innere Medizin (2731-7080), 2024, v. 65, n. 7, p. 664, doi. 10.1007/s00108-024-01734-y
- By:
- Publication type:
- Article
Regional socioeconomic deprivation associated with the use of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists in adults with type 2 diabetes in Germany.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 4116, doi. 10.1111/dom.15741
- By:
- Publication type:
- Article
Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon‐like peptide‐1 receptor agonist: A retrospective analysis of the Diabetes Prospective Follow‐Up Registry.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1813, doi. 10.1111/dom.15038
- By:
- Publication type:
- Article
Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow‐up (Germany/Austria) registries.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1577, doi. 10.1111/dom.14069
- By:
- Publication type:
- Article
Renal neuroendocrine tumors: clinical and molecular pathology with an emphasis on frequent association with ectopic Cushing syndrome.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 4, p. 465, doi. 10.1007/s00428-023-03596-5
- By:
- Publication type:
- Article
Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 3, p. 507, doi. 10.1007/s00428-022-03484-4
- By:
- Publication type:
- Article
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 10, p. 2372, doi. 10.1007/s00259-020-04709-x
- By:
- Publication type:
- Article
Prognostic Significance of Somatostatin Receptor Heterogeneity in Progressive Neuroendocrine Tumor Treated with Lu-177 DOTATOC or Lu-177 DOTATATE.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 4, p. 881, doi. 10.1007/s00259-019-04439-9
- By:
- Publication type:
- Article
Role of Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 9, p. 1593, doi. 10.1007/s00259-016-3331-7
- By:
- Publication type:
- Article
Evaluation of meaningful change in bowel movement frequency for patients with carcinoid syndrome.
- Published in:
- Journal of Patient-Reported Outcomes, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1186/s41687-019-0153-y
- By:
- Publication type:
- Article
Neuroendocrine Tumors of the Bronchopulmonary System (Typical and Atypical Carcinoid Tumors): Current Strategies in Diagnosis and Treatment. Conclusions of an Expert Meeting February 2011 in Weimar, Germany.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 5, p. 266, doi. 10.1159/000362430
- By:
- Publication type:
- Article
Practical Management of Everolimus-Related Toxicities in Patients with Advanced Solid Tumors.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 5, p. 295, doi. 10.1159/000350625
- By:
- Publication type:
- Article
Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas.
- Published in:
- Clinical Endocrinology, 2005, v. 62, n. 4, p. 434, doi. 10.1111/j.1365-2265.2005.02238.x
- By:
- Publication type:
- Article
Streptozotocin, 1982–2022: Forty Years from the FDA's Approval to Treat Pancreatic Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2022, v. 112, n. 12, p. 1155, doi. 10.1159/000524988
- By:
- Publication type:
- Article
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
- Published in:
- Neuroendocrinology, 2022, v. 112, n. 3, p. 298, doi. 10.1159/000516958
- By:
- Publication type:
- Article
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 9, p. 831, doi. 10.1159/000510445
- By:
- Publication type:
- Article
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome – An International Consensus Statement.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 7, p. 609, doi. 10.1159/000511791
- By:
- Publication type:
- Article
Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 6, p. 517, doi. 10.1159/000503144
- By:
- Publication type:
- Article
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms.
- Published in:
- Neuroendocrinology, 2019, v. 108, n. 1, p. 18, doi. 10.1159/000493319
- By:
- Publication type:
- Article
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary.
- Published in:
- Neuroendocrinology, 2018, v. 106, n. 3, p. 211, doi. 10.1159/000477585
- By:
- Publication type:
- Article
Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features.
- Published in:
- Neuroendocrinology, 2018, v. 106, n. 2, p. 139, doi. 10.1159/000474941
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy -- Chemotherapy.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 281, doi. 10.1159/000473892
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy -- Biotherapy and Novel Targeted Agents.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 266, doi. 10.1159/000471880
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 245, doi. 10.1159/000461583
- By:
- Publication type:
- Article